Assessment on efficacy of adjuvant intraperitoneal chemotherapy on advanced gastric carcinoma after radical treatment

Xin-han ZHAO,xin MA,Hong-gang TIAN
DOI: https://doi.org/10.3969/j.issn.1672-4992.2005.06.029
2005-01-01
Journal of Modern Oncology
Abstract:Objective To observe whether the efficacy of systemic venous chemotherapy plus intraperitoneal chemotherapy for patients with phase II~III gastric carcinoma was better than that of venous chemotherapy alone. Methods From January to December 2000, 58 patients with phase II~III gastric carcinoma after radical treatment were selected and treated by radical surgery, and divided randomly into two groups with different treatments (the systemic venous chemotherapy plus chemotherapy in the abdominal cavity was given to the treatment group, and venous chemotherapy alone to the control group), conducting follow-up survey. Results With the comparison of the recurrence rate of the two groups in three years, in the treatment group, the recurrence rate (17.2%) was lower than that of the control group (44.4%), and the survival rate (86.2%) was higher than that of the control group (59.3%). There were statistical differences between the two groups for both rates (P< 0.05), and the toxicity and side effects of the two groups had no prominent differences (P>0.05). Conclusion The efficacy of systemic venous chemotherapy plus intraperitoneal chemotherapy for patients with phase II~III gastric carcinoma after radical treatment was better than that of venous chemotherapy alone. The toxicity and side effects of systemic venous chemotherapy plus intraperitoneal chemotherapy group were not apparently higher than those of the venous chemotherapy group.
What problem does this paper attempt to address?